These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 15561647)

  • 1. Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia.
    Parsons B; Tive L; Huang S
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):157-62. PubMed ID: 15561647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Rauck RL; Irving GA; Wallace MS; Vanhove GF; Sweeney M
    J Pain Symptom Manage; 2013 Aug; 46(2):219-28. PubMed ID: 23149085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial.
    Irving G; Jensen M; Cramer M; Wu J; Chiang YK; Tark M; Wallace M
    Clin J Pain; 2009; 25(3):185-92. PubMed ID: 19333167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine, gabapentin, or their combination for neuropathic pain.
    Gilron I; Bailey JM; Tu D; Holden RR; Weaver DF; Houlden RL
    N Engl J Med; 2005 Mar; 352(13):1324-34. PubMed ID: 15800228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of gabapentin for treatment of postherpetic neuralgia: a meta-analysis of randomized controlled trials.
    Meng FY; Zhang LC; Liu Y; Pan LH; Zhu M; Li CL; Li YW; Qian W; Liang R
    Minerva Anestesiol; 2014 May; 80(5):556-67. PubMed ID: 24257149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different doses of gabapentin formulations for postherpetic neuralgia: A systematical review and meta-analysis of randomized controlled trials.
    Wang J; Zhu Y
    J Dermatolog Treat; 2017 Feb; 28(1):65-77. PubMed ID: 27798973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN).
    Sang CN; Sathyanarayana R; Sweeney M;
    Clin J Pain; 2013 Apr; 29(4):281-8. PubMed ID: 22801243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin.
    Backonja MM; Canafax DM; Cundy KC
    Pain Med; 2011 Jul; 12(7):1098-108. PubMed ID: 21627766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.
    Rowbotham M; Harden N; Stacey B; Bernstein P; Magnus-Miller L
    JAMA; 1998 Dec; 280(21):1837-42. PubMed ID: 9846778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
    Gore M; Sadosky A; Tai KS; Stacey B
    Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety of gastroretentive gabapentin in postherpetic neuralgia patients.
    Jensen MP; Irving G; Rauck R; Wallace M; Sweeney M; Vanhove GF
    Clin J Pain; 2013 Sep; 29(9):770-4. PubMed ID: 23370075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study.
    Yamauchi T; Kaneko S; Yagi K; Sase S
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):507-15. PubMed ID: 16884455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of gabapentin 1800 mg treatment for post-herpetic neuralgia: a meta-analysis of randomized controlled trials.
    Fan H; Yu W; Zhang Q; Cao H; Li J; Wang J; Shao Y; Hu X
    J Clin Pharm Ther; 2014 Aug; 39(4):334-42. PubMed ID: 24806220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study.
    Wallace MS; Irving G; Cowles VE
    Clin Drug Investig; 2010; 30(11):765-76. PubMed ID: 20818838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of gabapentin for the treatment of postherpetic neuralgia.
    Singh D; Kennedy DH
    Clin Ther; 2003 Mar; 25(3):852-89. PubMed ID: 12852705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Starting dose of gabapentin for patients with post-herpetic neuralgia--a dose-response study.
    Jean WH; Wu CC; Mok MS; Sun WZ
    Acta Anaesthesiol Taiwan; 2005 Jun; 43(2):73-7. PubMed ID: 16060401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin: new drug. Very similar to gabapentin.
    Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabapentin for chronic neuropathic pain in adults.
    Wiffen PJ; Derry S; Bell RF; Rice AS; Tölle TR; Phillips T; Moore RA
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007938. PubMed ID: 28597471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of gabapentin in patients experiencing hot flashes.
    Brown JN; Wright BR
    Pharmacotherapy; 2009 Jan; 29(1):74-81. PubMed ID: 19113798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.